Structure

Physi-Chem Properties

Molecular Weight:  402.11
Volume:  410.538
LogP:  5.201
LogD:  2.433
LogS:  -3.643
# Rotatable Bonds:  2
TPSA:  115.06
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.474
Synthetic Accessibility Score:  3.102
Fsp3:  0.083
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  2

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.838
MDCK Permeability:  1.1317488315398805e-05
Pgp-inhibitor:  0.103
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.025
20% Bioavailability (F20%):  0.181
30% Bioavailability (F30%):  0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  99.07423400878906%
Volume Distribution (VD):  0.345
Pgp-substrate:  2.4534943103790283%

ADMET: Metabolism

CYP1A2-inhibitor:  0.835
CYP1A2-substrate:  0.444
CYP2C19-inhibitor:  0.453
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.685
CYP2C9-substrate:  0.216
CYP2D6-inhibitor:  0.201
CYP2D6-substrate:  0.157
CYP3A4-inhibitor:  0.16
CYP3A4-substrate:  0.135

ADMET: Excretion

Clearance (CL):  3.27
Half-life (T1/2):  0.084

ADMET: Toxicity

hERG Blockers:  0.034
Human Hepatotoxicity (H-HT):  0.151
Drug-inuced Liver Injury (DILI):  0.944
AMES Toxicity:  0.796
Rat Oral Acute Toxicity:  0.442
Maximum Recommended Daily Dose:  0.977
Skin Sensitization:  0.941
Carcinogencity:  0.773
Eye Corrosion:  0.003
Eye Irritation:  0.859
Respiratory Toxicity:  0.095

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC58685

Natural Product ID:  NPC58685
Common Name*:   Ethylidene-6,6'-Biplumbagin
IUPAC Name:   5-hydroxy-6-[1-(1-hydroxy-6-methyl-5,8-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione
Synonyms:   Ethylidene-6,6'-Biplumbagin
Standard InCHIKey:  QIJWTOJFMIXPTB-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C24H18O6/c1-10-8-17(25)19-15(21(10)27)6-4-13(23(19)29)12(3)14-5-7-16-20(24(14)30)18(26)9-11(2)22(16)28/h4-9,12,29-30H,1-3H3
SMILES:  CC1=CC(=O)c2c(ccc(C(C)c3ccc4c(C(=O)C=C(C)C4=O)c3O)c2O)C1=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2023570
PubChem CID:   14163338
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000023] Naphthalenes
        • [CHEMONTID:0000153] Naphthoquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota bark Indonesia n.a. PMID[15270571]
NPO33133 barleria alluaudii Species Acanthaceae Eukaryota n.a. n.a. n.a. PMID[22313254]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. PMID[22313254]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16657 Diospyros maritima Species Ebenaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT369 Cell Line ACHN Homo sapiens EC50 > 30000.0 nM PMID[456416]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC58685 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9603 High Similarity NPC34414
0.9603 High Similarity NPC146647
0.9528 High Similarity NPC55949
0.9462 High Similarity NPC283088
0.9457 High Similarity NPC115458
0.937 High Similarity NPC282923
0.9365 High Similarity NPC3224
0.9308 High Similarity NPC53896
0.9302 High Similarity NPC244699
0.9242 High Similarity NPC272268
0.9237 High Similarity NPC50924
0.9219 High Similarity NPC48248
0.9206 High Similarity NPC142956
0.9173 High Similarity NPC245923
0.9173 High Similarity NPC305060
0.9154 High Similarity NPC205992
0.9154 High Similarity NPC17083
0.9147 High Similarity NPC99731
0.9134 High Similarity NPC103540
0.9098 High Similarity NPC474813
0.9091 High Similarity NPC287604
0.9091 High Similarity NPC161964
0.9091 High Similarity NPC472262
0.9055 High Similarity NPC173978
0.9048 High Similarity NPC307174
0.9015 High Similarity NPC225051
0.8976 High Similarity NPC375356
0.8971 High Similarity NPC181560
0.8971 High Similarity NPC169452
0.8963 High Similarity NPC13715
0.8939 High Similarity NPC70622
0.8915 High Similarity NPC231774
0.8915 High Similarity NPC306765
0.8898 High Similarity NPC300274
0.8897 High Similarity NPC138099
0.8897 High Similarity NPC242994
0.8881 High Similarity NPC80035
0.8872 High Similarity NPC114183
0.8864 High Similarity NPC474517
0.8864 High Similarity NPC72669
0.8841 High Similarity NPC193555
0.8841 High Similarity NPC239136
0.8841 High Similarity NPC19631
0.8832 High Similarity NPC315578
0.8832 High Similarity NPC225243
0.8815 High Similarity NPC193358
0.8815 High Similarity NPC155211
0.881 High Similarity NPC285829
0.881 High Similarity NPC206778
0.8806 High Similarity NPC288089
0.8806 High Similarity NPC270899
0.8806 High Similarity NPC12070
0.8797 High Similarity NPC246693
0.8797 High Similarity NPC242358
0.8797 High Similarity NPC110609
0.8788 High Similarity NPC136588
0.8788 High Similarity NPC31799
0.8788 High Similarity NPC199253
0.8779 High Similarity NPC96024
0.8777 High Similarity NPC471682
0.8769 High Similarity NPC96915
0.8759 High Similarity NPC1268
0.8759 High Similarity NPC26924
0.875 High Similarity NPC53206
0.875 High Similarity NPC53414
0.875 High Similarity NPC471905
0.8741 High Similarity NPC161632
0.8741 High Similarity NPC249272
0.8712 High Similarity NPC278928
0.8705 High Similarity NPC257644
0.8702 High Similarity NPC471530
0.8696 High Similarity NPC96421
0.8686 High Similarity NPC416
0.8686 High Similarity NPC61398
0.8676 High Similarity NPC315275
0.8676 High Similarity NPC254847
0.8667 High Similarity NPC282780
0.8667 High Similarity NPC166480
0.8657 High Similarity NPC309430
0.8652 High Similarity NPC471683
0.8633 High Similarity NPC124365
0.8633 High Similarity NPC246638
0.8615 High Similarity NPC199273
0.8615 High Similarity NPC310540
0.8613 High Similarity NPC53001
0.8613 High Similarity NPC62272
0.8603 High Similarity NPC258502
0.8593 High Similarity NPC314048
0.8593 High Similarity NPC52407
0.8593 High Similarity NPC254603
0.8571 High Similarity NPC474300
0.8571 High Similarity NPC109123
0.8571 High Similarity NPC135524
0.8561 High Similarity NPC72667
0.8551 High Similarity NPC87723
0.8551 High Similarity NPC4214
0.854 High Similarity NPC474311
0.854 High Similarity NPC141934
0.854 High Similarity NPC191976
0.8538 High Similarity NPC275145
0.8529 High Similarity NPC44437
0.8519 High Similarity NPC175738
0.8511 High Similarity NPC313047
0.8511 High Similarity NPC474203
0.8511 High Similarity NPC451542
0.8511 High Similarity NPC295712
0.8511 High Similarity NPC476473
0.8507 High Similarity NPC475741
0.8507 High Similarity NPC198305
0.85 High Similarity NPC305845
0.85 High Similarity NPC187843
0.85 High Similarity NPC477275
0.85 High Similarity NPC204045
0.8492 Intermediate Similarity NPC108288
0.8492 Intermediate Similarity NPC477453
0.8489 Intermediate Similarity NPC143438
0.8489 Intermediate Similarity NPC295339
0.8485 Intermediate Similarity NPC1991
0.8485 Intermediate Similarity NPC160499
0.8485 Intermediate Similarity NPC254492
0.8483 Intermediate Similarity NPC315520
0.8478 Intermediate Similarity NPC36868
0.8473 Intermediate Similarity NPC68756
0.8473 Intermediate Similarity NPC234890
0.8473 Intermediate Similarity NPC236189
0.8473 Intermediate Similarity NPC152525
0.8473 Intermediate Similarity NPC74507
0.8462 Intermediate Similarity NPC85393
0.8462 Intermediate Similarity NPC110882
0.8462 Intermediate Similarity NPC282577
0.8462 Intermediate Similarity NPC147250
0.8462 Intermediate Similarity NPC271944
0.8456 Intermediate Similarity NPC267205
0.8451 Intermediate Similarity NPC29932
0.8451 Intermediate Similarity NPC193703
0.8451 Intermediate Similarity NPC477913
0.8451 Intermediate Similarity NPC21599
0.8451 Intermediate Similarity NPC10764
0.8444 Intermediate Similarity NPC41847
0.8444 Intermediate Similarity NPC85342
0.844 Intermediate Similarity NPC69755
0.844 Intermediate Similarity NPC469520
0.8433 Intermediate Similarity NPC276238
0.8433 Intermediate Similarity NPC25736
0.8433 Intermediate Similarity NPC171460
0.8429 Intermediate Similarity NPC241349
0.8429 Intermediate Similarity NPC327916
0.8429 Intermediate Similarity NPC42262
0.8429 Intermediate Similarity NPC220496
0.8429 Intermediate Similarity NPC32749
0.8429 Intermediate Similarity NPC147542
0.8429 Intermediate Similarity NPC37992
0.8421 Intermediate Similarity NPC69424
0.8421 Intermediate Similarity NPC176130
0.8421 Intermediate Similarity NPC78364
0.8421 Intermediate Similarity NPC84672
0.8417 Intermediate Similarity NPC230811
0.8417 Intermediate Similarity NPC61590
0.8413 Intermediate Similarity NPC161304
0.8406 Intermediate Similarity NPC472308
0.8406 Intermediate Similarity NPC86524
0.8406 Intermediate Similarity NPC118919
0.8403 Intermediate Similarity NPC37709
0.8394 Intermediate Similarity NPC1249
0.8392 Intermediate Similarity NPC170055
0.8392 Intermediate Similarity NPC34482
0.8385 Intermediate Similarity NPC154696
0.838 Intermediate Similarity NPC293545
0.838 Intermediate Similarity NPC296752
0.838 Intermediate Similarity NPC174905
0.837 Intermediate Similarity NPC31539
0.837 Intermediate Similarity NPC108129
0.8369 Intermediate Similarity NPC106519
0.8369 Intermediate Similarity NPC91019
0.8358 Intermediate Similarity NPC237225
0.8358 Intermediate Similarity NPC165257
0.8357 Intermediate Similarity NPC111422
0.8357 Intermediate Similarity NPC470407
0.8357 Intermediate Similarity NPC216312
0.8357 Intermediate Similarity NPC29771
0.8357 Intermediate Similarity NPC190457
0.8357 Intermediate Similarity NPC306835
0.8357 Intermediate Similarity NPC476477
0.8357 Intermediate Similarity NPC471602
0.8357 Intermediate Similarity NPC256463
0.8357 Intermediate Similarity NPC299405
0.8356 Intermediate Similarity NPC205766
0.8346 Intermediate Similarity NPC71610
0.8346 Intermediate Similarity NPC49647
0.8346 Intermediate Similarity NPC227741
0.8346 Intermediate Similarity NPC474106
0.8346 Intermediate Similarity NPC295202
0.8346 Intermediate Similarity NPC136342
0.8345 Intermediate Similarity NPC471452
0.8333 Intermediate Similarity NPC290803
0.8333 Intermediate Similarity NPC22222
0.8333 Intermediate Similarity NPC470570
0.8333 Intermediate Similarity NPC136878
0.8333 Intermediate Similarity NPC281513
0.8333 Intermediate Similarity NPC285122

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC58685 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9134 High Similarity NPD1470 Approved
0.8819 High Similarity NPD1201 Approved
0.8676 High Similarity NPD1509 Clinical (unspecified phase)
0.8613 High Similarity NPD5404 Approved
0.8613 High Similarity NPD5405 Approved
0.8613 High Similarity NPD5408 Approved
0.8613 High Similarity NPD5406 Approved
0.8492 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8264 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD7390 Discontinued
0.8156 Intermediate Similarity NPD2346 Discontinued
0.8125 Intermediate Similarity NPD3300 Phase 2
0.8041 Intermediate Similarity NPD3226 Approved
0.782 Intermediate Similarity NPD2932 Approved
0.773 Intermediate Similarity NPD943 Approved
0.7687 Intermediate Similarity NPD3019 Approved
0.7681 Intermediate Similarity NPD2798 Approved
0.7639 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD2799 Discontinued
0.7634 Intermediate Similarity NPD5951 Approved
0.7615 Intermediate Similarity NPD7635 Approved
0.7609 Intermediate Similarity NPD1164 Approved
0.7589 Intermediate Similarity NPD2313 Discontinued
0.7586 Intermediate Similarity NPD2935 Discontinued
0.7562 Intermediate Similarity NPD7473 Discontinued
0.7556 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2342 Discontinued
0.75 Intermediate Similarity NPD7003 Approved
0.7484 Intermediate Similarity NPD6232 Discontinued
0.7481 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7465 Intermediate Similarity NPD3764 Approved
0.7425 Intermediate Similarity NPD8150 Discontinued
0.7417 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD4878 Approved
0.7383 Intermediate Similarity NPD3750 Approved
0.7379 Intermediate Similarity NPD1607 Approved
0.7372 Intermediate Similarity NPD7819 Suspended
0.7338 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD6959 Discontinued
0.7303 Intermediate Similarity NPD2532 Approved
0.7303 Intermediate Similarity NPD2534 Approved
0.7303 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD2533 Approved
0.7297 Intermediate Similarity NPD2344 Approved
0.7279 Intermediate Similarity NPD1510 Phase 2
0.7252 Intermediate Similarity NPD4750 Phase 3
0.7246 Intermediate Similarity NPD3023 Approved
0.7246 Intermediate Similarity NPD3026 Approved
0.7246 Intermediate Similarity NPD8312 Approved
0.7246 Intermediate Similarity NPD8313 Approved
0.7241 Intermediate Similarity NPD1240 Approved
0.7235 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD5031 Approved
0.7229 Intermediate Similarity NPD5029 Approved
0.7229 Intermediate Similarity NPD5027 Approved
0.7226 Intermediate Similarity NPD3025 Approved
0.7226 Intermediate Similarity NPD3024 Approved
0.7215 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD1930 Approved
0.7188 Intermediate Similarity NPD1929 Approved
0.7188 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD4380 Phase 2
0.7176 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD74 Approved
0.7176 Intermediate Similarity NPD9266 Approved
0.7174 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD1283 Approved
0.7152 Intermediate Similarity NPD8166 Discontinued
0.7152 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD9493 Approved
0.7115 Intermediate Similarity NPD7458 Discontinued
0.7105 Intermediate Similarity NPD2309 Approved
0.7101 Intermediate Similarity NPD1651 Approved
0.7099 Intermediate Similarity NPD9267 Approved
0.7099 Intermediate Similarity NPD9263 Approved
0.7099 Intermediate Similarity NPD9264 Approved
0.7086 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD4954 Approved
0.7083 Intermediate Similarity NPD4955 Approved
0.7083 Intermediate Similarity NPD36 Approved
0.7083 Intermediate Similarity NPD5026 Approved
0.7083 Intermediate Similarity NPD5028 Approved
0.7083 Intermediate Similarity NPD5034 Approved
0.7067 Intermediate Similarity NPD1471 Phase 3
0.7067 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD288 Approved
0.7063 Intermediate Similarity NPD7768 Phase 2
0.7052 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD3748 Approved
0.7042 Intermediate Similarity NPD1876 Approved
0.7039 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD7008 Discontinued
0.7034 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD7411 Suspended
0.7024 Intermediate Similarity NPD5030 Phase 2
0.702 Intermediate Similarity NPD1549 Phase 2
0.7019 Intermediate Similarity NPD3749 Approved
0.7018 Intermediate Similarity NPD5037 Approved
0.7018 Intermediate Similarity NPD5038 Approved
0.7007 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4879 Approved
0.7 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD1551 Phase 2
0.7 Intermediate Similarity NPD6100 Approved
0.7 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.6993 Remote Similarity NPD1203 Approved
0.6984 Remote Similarity NPD844 Approved
0.6977 Remote Similarity NPD1932 Approved
0.6974 Remote Similarity NPD2800 Approved
0.6971 Remote Similarity NPD6535 Approved
0.6971 Remote Similarity NPD6534 Approved
0.696 Remote Similarity NPD845 Approved
0.6959 Remote Similarity NPD5036 Approved
0.6954 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6954 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6953 Remote Similarity NPD2066 Phase 3
0.6953 Remote Similarity NPD3020 Approved
0.695 Remote Similarity NPD1281 Approved
0.695 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6020 Phase 2
0.6939 Remote Similarity NPD6663 Approved
0.6937 Remote Similarity NPD2801 Approved
0.6936 Remote Similarity NPD6836 Approved
0.6933 Remote Similarity NPD5494 Approved
0.6933 Remote Similarity NPD4308 Phase 3
0.6929 Remote Similarity NPD4626 Approved
0.6929 Remote Similarity NPD3495 Discontinued
0.6923 Remote Similarity NPD6273 Approved
0.6918 Remote Similarity NPD4625 Phase 3
0.6917 Remote Similarity NPD2329 Discontinued
0.6914 Remote Similarity NPD6212 Phase 3
0.6914 Remote Similarity NPD7075 Discontinued
0.6914 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6213 Phase 3
0.6913 Remote Similarity NPD6651 Approved
0.6906 Remote Similarity NPD7009 Phase 2
0.6903 Remote Similarity NPD1511 Approved
0.6901 Remote Similarity NPD3972 Approved
0.6897 Remote Similarity NPD5736 Approved
0.6889 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6887 Remote Similarity NPD2796 Approved
0.6886 Remote Similarity NPD7177 Discontinued
0.6875 Remote Similarity NPD2797 Approved
0.6875 Remote Similarity NPD1934 Approved
0.6871 Remote Similarity NPD411 Approved
0.6871 Remote Similarity NPD3268 Approved
0.687 Remote Similarity NPD1237 Approved
0.6867 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6866 Remote Similarity NPD3022 Approved
0.6866 Remote Similarity NPD3021 Approved
0.6861 Remote Similarity NPD9281 Approved
0.6854 Remote Similarity NPD7700 Phase 2
0.6854 Remote Similarity NPD7699 Phase 2
0.6853 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6852 Remote Similarity NPD3882 Suspended
0.6845 Remote Similarity NPD5844 Phase 1
0.6842 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6835 Remote Similarity NPD7610 Discontinued
0.6832 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6824 Remote Similarity NPD6559 Discontinued
0.6818 Remote Similarity NPD4628 Phase 3
0.6815 Remote Similarity NPD1512 Approved
0.6794 Remote Similarity NPD9261 Approved
0.679 Remote Similarity NPD5402 Approved
0.6786 Remote Similarity NPD3091 Approved
0.6784 Remote Similarity NPD5032 Approved
0.6783 Remote Similarity NPD9717 Approved
0.6783 Remote Similarity NPD1608 Approved
0.6779 Remote Similarity NPD2979 Phase 3
0.6778 Remote Similarity NPD6782 Approved
0.6778 Remote Similarity NPD6779 Approved
0.6778 Remote Similarity NPD6777 Approved
0.6778 Remote Similarity NPD6776 Approved
0.6778 Remote Similarity NPD6778 Approved
0.6778 Remote Similarity NPD6781 Approved
0.6778 Remote Similarity NPD6780 Approved
0.677 Remote Similarity NPD6844 Discontinued
0.6761 Remote Similarity NPD5968 Phase 3
0.6752 Remote Similarity NPD7004 Clinical (unspecified phase)
0.675 Remote Similarity NPD6599 Discontinued
0.6747 Remote Similarity NPD5710 Approved
0.6747 Remote Similarity NPD5711 Approved
0.6746 Remote Similarity NPD7631 Approved
0.6744 Remote Similarity NPD5035 Approved
0.6739 Remote Similarity NPD497 Approved
0.6735 Remote Similarity NPD6832 Phase 2
0.6733 Remote Similarity NPD447 Suspended
0.6731 Remote Similarity NPD6884 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5033 Approved
0.6721 Remote Similarity NPD8320 Phase 1
0.6721 Remote Similarity NPD8319 Approved
0.6719 Remote Similarity NPD2859 Approved
0.6719 Remote Similarity NPD2860 Approved
0.6713 Remote Similarity NPD3092 Approved
0.6712 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6707 Remote Similarity NPD4381 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data